Results 111 to 120 of about 28,240 (212)

Endocrine Abnormalities and Growth Pattern in Single Large‐Scale Mitochondrial DNA Deletion Syndromes

open access: yesActa Paediatrica, Volume 114, Issue 8, Page 1857-1867, August 2025.
ABSTRACT Aim To assess the prevalence of endocrine disorders and investigate growth patterns in single large‐scale mitochondrial DNA deletion syndromes (SLSMDs). Methods A retrospective study of all children with SLSMD who attended Sheba Medical Center, Israel, from February 2017 to September 2024.
Ayman Daka   +7 more
wiley   +1 more source

Blood Pressure–Lowering Effects of Aldosterone Synthase Inhibitors—A Systematic Review

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 137, Issue 2, August 2025.
ABSTRACT Excess aldosterone production contributes to the development of hypertension and results in fibrosis with dysfunction of the heart, vasculature and kidneys. Consequently, new agents have been developed to reduce endogenous aldosterone synthesis.
Anders Almskou Rasmussen   +3 more
wiley   +1 more source

Spironolactone inhibits the NLRP1 inflammasome and alleviates defective erythropoiesis in Diamond-Blackfan anemia. [PDF]

open access: yesHemasphere
Rodríguez-Ruiz L   +15 more
europepmc   +1 more source

Advancing antihypertensive drug development

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 15, Page 3389-3410, August 2025.
Hypertension affects more than a billion individuals worldwide and remains a major cause of cardiovascular morbidity and mortality. Despite advances in therapies, optimal blood pressure control remains elusive for many patients because of treatment resistance, adverse effects, and adherence challenges.
Fay Pu   +5 more
wiley   +1 more source

Efficacy, Quality of Life, and Cost‐Effectiveness of Superselective Adrenal Arterial Embolization in Idiopathic Hyperaldosteronism: A Comparative Study

open access: yesThe Journal of Clinical Hypertension, Volume 27, Issue 8, August 2025.
ABSTRACT Idiopathic hyperaldosteronism (IHA) is the most common subtype of primary aldosteronism, typically managed with mineralocorticoid receptor antagonists (MRAs). However, long‐term MRA therapy is associated with suboptimal cardiovascular outcomes and adverse effects.
Nouman Ali Khan   +16 more
wiley   +1 more source

Apparent Mineralocorticoid Excess Syndrome: Case Report. [PDF]

open access: yesInt Med Case Rep J
Alsaadoun SA   +3 more
europepmc   +1 more source

Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress [PDF]

open access: bronze, 2002
Agostino Virdis   +5 more
openalex   +1 more source

Research Trends and Hotspots in Female Pattern Hair Loss: A Bibliometric Study

open access: yesJournal of Cosmetic Dermatology, Volume 24, Issue 8, August 2025.
ABSTRACT Background Female pattern hair loss (FPHL) is a common yet understudied condition with significant psychosocial impacts. Understanding global research trends and emerging topics in FPHL is essential for guiding future investigations. Aims This bibliometric analysis aimed to provide an overview of key trends, influential contributors, and ...
Hongjuan Fu
wiley   +1 more source

Home - About - Disclaimer - Privacy